eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
6/2010
vol. 27
 
Share:
Send email
Share:
abstract:

Review paper
Bone metabolism disorders and glucocorticoid therapy in patients with pemphigus

Marlena Karlińska
,
Elżbieta Waszczykowska
,
Jolanta Dorota Torzecka

Post Dermatol Alergol 2010; XXVII, 6: 484–489
Online publish date: 2010/12/29
View full text Get citation
 
Glucocorticoids are the most common cause of secondary osteoporosis, defined as a chronic, progressive disorder characterized by low bone mass and microarchitectural deterioration of bone tissue. The consequence is impairment of bone endurance and increased susceptibility to fracture. It is estimated that 30% to 50% of patients experience vertebral or hip fractures. The highest risk of reduction in bone density is observed in the first 3-6 months of treatment. Glucocorticoids in association with immunosuppressive drugs are still the main method of pemphigus therapy. Most patients undergoing chronic glucocorticoid treatment do not receive optimal osteoporosis diagnosis, prevention and/or treatment.
keywords:

pemphigus, glucocorticoid therapy, osteoporosis
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.